Literature DB >> 15036248

Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.

Deanne M R Lathers1, M Rita I Young.   

Abstract

Patients with head and neck squamous cell carcinoma (HNSCC) are biased toward the Th2 phenotype as they have increased levels of the Th2 cytokines IL-4, IL-6 and IL-10 and diminished levels of the Th1 cytokine IFN-gamma. However, this bias is incomplete since levels of the Th1 cytokines IL-2 and GM-CSF are increased. This study examined the interrelationship among the plasma levels of Th1 and Th2 cytokines in 101 HNSCC patients and 40 age-matched controls without a known malignancy. Control subjects showed extensive interrelationships among levels of IL-1, IL-2, IL-4, and IFN-gamma, as well as between GM-CSF and TGF-beta. HNSCC patients showed an interrelationship in levels of IL-2, IL-4, IFN-gamma and GM-CSF, but to a less significant degree. What was prominent was a decline in correlation among cytokine levels with increased disease burden, such that there were no relationships among any of the cytokines in stage T4 patients. Nodal involvement also was associated with cytokine levels being more independent of each other, although the impact of nodal disease was less prominent than tumor burden. These results show a partial Th2 cytokine bias in HNSCC patients and a progressively more aberrant expression of cytokines with more advanced disease.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15036248     DOI: 10.1016/j.cyto.2003.11.005

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  31 in total

1.  Association of Interleukin-4 Polymorphisms With Breast Cancer in Taiwan.

Authors:  Chia-Wen Tsai; Chien-Chih Yu; DA-Tian Bau; Chin-Nan Chu; Yun-Chi Wang; Wen-Shin Chang; Zhi-Hong Wang; Liang-Chih Liu; Shao-Chun Wang; Cheng-Chieh Lin; Ting-Yuan Liu; Jan-Gowth Chang
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 2.  Human leukocyte antigen (HLA) class I defects in head and neck cancer: molecular mechanisms and clinical significance.

Authors:  Robert L Ferris; Jennifer L Hunt; Soldano Ferrone
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

3.  Tumor-associated macrophages in the cutaneous SCC microenvironment are heterogeneously activated.

Authors:  Julia S Pettersen; Judilyn Fuentes-Duculan; Mayte Suárez-Fariñas; Katherine C Pierson; Alexander Pitts-Kiefer; Linda Fan; Daniel A Belkin; Claire Q F Wang; Shivaprasad Bhuvanendran; Leanne M Johnson-Huang; Mark J Bluth; James G Krueger; Michelle A Lowes; John A Carucci
Journal:  J Invest Dermatol       Date:  2011-02-10       Impact factor: 8.551

4.  Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.

Authors:  Michael S Leibowitz; Pedro A Andrade Filho; Soldano Ferrone; Robert L Ferris
Journal:  Cancer Immunol Immunother       Date:  2011-01-05       Impact factor: 6.968

Review 5.  Immunology and Immunotherapy of Head and Neck Cancer.

Authors:  Robert L Ferris
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

6.  Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma.

Authors:  Cristiane H Squarize; Rogerio M Castilho; Virote Sriuranpong; Decio S Pinto; Jorge Silvio Gutkind
Journal:  Neoplasia       Date:  2006-09       Impact factor: 5.715

7.  Differences in tumor stroma derived from irradiated versus non-irradiated fibroblasts in a co-culture model with head and neck squamous cell carcinoma.

Authors:  Thomas Gehrke; Agmal Scherzad; Stephan Hackenberg; Philipp Schendzielorz; Rudolf Hagen; Norbert Kleinsasser
Journal:  Oncol Lett       Date:  2016-09-01       Impact factor: 2.967

Review 8.  Current understanding of the tumor microenvironment of laryngeal dysplasia and progression to invasive cancer.

Authors:  Sumita Trivedi; Clark A Rosen; Robert L Ferris
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2016-04       Impact factor: 2.064

9.  Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis.

Authors:  Pawan Kumar; Arti Yadav; Samip N Patel; Mozaffarul Islam; Quintin Pan; Sofia D Merajver; Theodoros N Teknos
Journal:  Mol Cancer       Date:  2010-08-03       Impact factor: 27.401

10.  Intratumoral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.

Authors:  Jeffrey S Moyer; Ji Li; Shuang Wei; Seagal Teitz-Tennenbaum; Alfred E Chang
Journal:  J Immunother       Date:  2008 Nov-Dec       Impact factor: 4.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.